Dalton Pharma News

News & Events

Welcome to Dalton Pharma Services News and Events.

On this page you will find our current and past news releases and a list of event happenings. If you can't find what you are looking for, please contact us and we will be happy to provide you with assistance.

6/27/2024 00:00 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product

Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that Dalton Pharma Services (Dalton) has completed the good manufacturing practice (GMP) glass vial filling stage for cilastatin, the Company’s second drug candidate for preventing acute kidney injury (AKI).

6/5/2024 10:00 Dalton Pharma Services Invests in Robotic Aseptic Powder Fill-Finish Line from 3P innovation

Pharmaceutical manufacturing company, Dalton Pharma Services (a Seikagaku Group company), has recently commissioned 3P innovation (Warwick, UK) to design and construct a fully automated state-of-the-art high-speed aseptic powder filling line to expedite the delivery of drugs to market in a more compliant, efficient, and economical manner.

1/19/2024 00:00 Another Exciting Academic Tour at Dalton: Welcoming McGill University

Dalton recently hosted an academic tour for students from McGill University, showcasing our expanding state-of-the-art facilities and our commitment to nurturing future scientific talent.

2/16/2023 00:00 Dalton Announces Major Expansion in Commercial Sterile Manufacturing Capacity

The capital expansion plan includes a new state-of-the-art, fully automated cGMP sterile filling line with the flexibility to fill vials, syringes, and cartridges under isolator technology.

6/15/2022 00:00 Dalton Receives Approval for Cannabis Analytical Test Licence

Dalton Pharma Services is pleased to announce its recent approval for the Cannabis Analytical Test Licence from Health Canada under the Cannabis Act and Cannabis Regulations.

12/21/2021 12:45 Dalton Pharma Services Supports Manufacturing of Arch BioPartner's LSALT Peptide Share Article

LSALT Peptide has recently entered the Canadian Treatments for COVID-19 Trial. Dalton Pharma Services has supported the development of LSALT Peptide through our fill and finish services in our state-of-the-art manufacturing facility.

10/26/2021 00:00 Dalton Pharma Services Partnership with TransMedics for their OCS Liver Transplantation System

TransMedics OCS Liver System was recently granted FDA premarket approval. Dalton Pharma Services is thrilled to be supporting the commercialization of this important novel technology and to be part of TransMedics success.

7/27/2021 09:56 Dalton Pharma Furthers Advance Formulation of Psilocybin for Diamond Therapeutics

Diamond Therapeutics Hires Industry Veteran David Brown, PhD, to Further Advance Formulation of Psilocybin by Dalton Pharma

5/17/2021 17:29 Cortalex™ is manufactured exclusively for Cardiol by Dalton Pharma Services

Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.

2/19/2021 00:00 Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke Program

Dalton is a Health Canada approved, and FDA inspected, GMP contract provider of integrated chemistry, drug development and manufacturing services to the pharmaceutical and biotechnology industries.